D-0612-2017 Class II Terminated
FDA drug recall D-0612-2017 was initiated by Fougera Pharmaceuticals Inc. on Mar 2, 2017 and is designated Class II. Reason for recall: Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream The recall status is terminated (terminated Jul 2, 2018). Affected quantity: 14,665 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 29, 2017
- Initiation Date
- Mar 2, 2017
- Termination Date
- Jul 2, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,665 tubes
Product description
Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60
Reason for recall
Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream
Distribution pattern
Nationwide
Code information
Lot GC9231 (exp. 05/2019); Lot GC9232 (exp. 05/2019)
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0612-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026